End Taxpayer Funding of Gender Experimentation Act of 2023

Bill 118 s 1595, also known as the End Taxpayer Funding of Gender Experimentation Act of 2023, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to prohibit the use of federal funds for gender reassignment surgeries and treatments.

If passed, this bill would prevent taxpayer dollars from being used to cover the costs of medical procedures and therapies related to gender transition. This includes surgeries such as hormone therapy and gender confirmation surgeries.

Supporters of the bill argue that taxpayer money should not be used to fund what they refer to as "gender experimentation." They believe that these procedures are not medically necessary and should not be covered by government funds. Opponents of the bill, on the other hand, argue that transgender individuals have the right to access necessary medical care, including gender-affirming treatments. They believe that denying coverage for these procedures is discriminatory and harmful to the transgender community. Overall, the End Taxpayer Funding of Gender Experimentation Act of 2023 is a controversial piece of legislation that raises important questions about the use of taxpayer funds for medical procedures related to gender transition. It is currently being debated in Congress, and its outcome remains uncertain.